Cardlytics (CDLX)
(Delayed Data from NSDQ)
$8.79 USD
-0.48 (-5.18%)
Updated May 17, 2024 04:00 PM ET
After-Market: $8.81 +0.02 (0.23%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CDLX 8.79 -0.48(-5.18%)
Will CDLX be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CDLX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CDLX
Cardlytics (CDLX) Reports Q2 Loss, Tops Revenue Estimates
Spotify (SPOT) Reports Q2 Loss, Lags Revenue Estimates
CDLX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cardlytics (CDLX) Surges 13.2%: Is This an Indication of Further Gains?
CleanSpark (CLSK) Soars 8.6%: Is Further Upside Left in the Stock?
Is Cardlytics (CDLX) Stock Outpacing Its Business Services Peers This Year?
Other News for CDLX
Commit To Buy Cardlytics At $5, Earn 24% Using Options
Cardlytics Inc (CDLX) Reports Q1 2024 Earnings: A Detailed Analysis
CCLD, SKYT and SEED among mid-day movers
What You Missed On Wall Street This Morning
Why Is Pop Culture Group (CPOP) Stock Up 84% Today?